Jennifer D. Venable

977 total citations
15 papers, 562 citations indexed

About

Jennifer D. Venable is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Jennifer D. Venable has authored 15 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Physiology. Recurrent topics in Jennifer D. Venable's work include Mast cells and histamine (6 papers), Asthma and respiratory diseases (4 papers) and Protein Degradation and Inhibitors (3 papers). Jennifer D. Venable is often cited by papers focused on Mast cells and histamine (6 papers), Asthma and respiratory diseases (4 papers) and Protein Degradation and Inhibitors (3 papers). Jennifer D. Venable collaborates with scholars based in United States, United Kingdom and Israel. Jennifer D. Venable's co-authors include Robin L. Thurmond, Lars Karlsson, Michael K. Ameriks, Siquan Sun, Navin Rao, James P. Edwards, Mai Zhang, Brad M. Savall, Jianmei Wei and Cheryl A. Grice and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Jennifer D. Venable

14 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer D. Venable United States 10 333 285 110 75 64 15 562
Kai-Ting Shade United States 7 301 0.9× 224 0.8× 130 1.2× 126 1.7× 29 0.5× 7 575
William Gillespie United States 12 181 0.5× 395 1.4× 40 0.4× 49 0.7× 74 1.2× 20 667
Yuntao Wan United States 13 273 0.8× 257 0.9× 296 2.7× 128 1.7× 19 0.3× 19 697
Vasilios A. Morikis United States 13 166 0.5× 252 0.9× 79 0.7× 110 1.5× 26 0.4× 21 504
Stéphane Téletchéa France 14 170 0.5× 323 1.1× 33 0.3× 16 0.2× 49 0.8× 29 612
Yuichi Kunori Japan 10 271 0.8× 168 0.6× 137 1.2× 115 1.5× 14 0.2× 12 484
K. Merétey Hungary 9 235 0.7× 121 0.4× 74 0.7× 47 0.6× 13 0.2× 19 450
Colleen Davenport United States 8 341 1.0× 173 0.6× 89 0.8× 52 0.7× 9 0.1× 13 425
Sébastien Flajollet France 12 231 0.7× 333 1.2× 35 0.3× 15 0.2× 20 0.3× 17 616
S D Sanderson United States 12 233 0.7× 293 1.0× 41 0.4× 20 0.3× 52 0.8× 16 491

Countries citing papers authored by Jennifer D. Venable

Since Specialization
Citations

This map shows the geographic impact of Jennifer D. Venable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer D. Venable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer D. Venable more than expected).

Fields of papers citing papers by Jennifer D. Venable

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer D. Venable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer D. Venable. The network helps show where Jennifer D. Venable may publish in the future.

Co-authorship network of co-authors of Jennifer D. Venable

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer D. Venable. A scholar is included among the top collaborators of Jennifer D. Venable based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer D. Venable. Jennifer D. Venable is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gelin, Christine F., Charu Chaudhry, Nadeem A. Vellore, et al.. (2025). Reductive C(sp2)–C(sp3) Coupling Protocol to Enable Linker Exploration of Cereblon E3-Ligase BRD4 Proteolysis-Targeting Chimeras. Journal of Medicinal Chemistry. 68(10). 10061–10074. 4 indexed citations
2.
Damm‐Ganamet, Kelly L., Clara Moon, Alan D. Wickenden, et al.. (2025). Allosteric modulation of the solute carrier transporter SLC39A8 potentiates manganese and cadmium uptake. Journal of Clinical Investigation. 135(21).
3.
Huang, Haiyan, Jean-François Brazeau, Christopher O. Audu, et al.. (2024). Modulating the Potency of BRD4 PROTACs at the Systems Level with Amine-Acid Coupling Reactions. Journal of Medicinal Chemistry. 68(1). 405–420. 5 indexed citations
4.
Hendrick, Charles E., Charu Chaudhry, Iulia I. Strambeanu, et al.. (2022). Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation. ACS Medicinal Chemistry Letters. 13(7). 1182–1190. 81 indexed citations
5.
Thurmond, Robin L., Jennifer D. Venable, Brad M. Savall, et al.. (2017). Clinical Development of Histamine H4 Receptor Antagonists. Handbook of experimental pharmacology. 241. 301–320. 36 indexed citations
6.
Tichenor, Mark S., Robin L. Thurmond, Jennifer D. Venable, & Brad M. Savall. (2015). Functional Profiling of 2-Aminopyrimidine Histamine H4Receptor Modulators. Journal of Medicinal Chemistry. 58(18). 7119–7127. 11 indexed citations
7.
Savall, Brad M., Jennifer D. Venable, Jianmei Wei, et al.. (2014). The effect of pKa on pyrimidine/pyridine-derived histamine H4 ligands. Bioorganic & Medicinal Chemistry Letters. 24(23). 5489–5492. 2 indexed citations
8.
Savall, Brad M., James P. Edwards, Jennifer D. Venable, et al.. (2010). Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20(11). 3367–3371. 18 indexed citations
9.
Venable, Jennifer D., Michael K. Ameriks, Jonathan M. Blevitt, Robin L. Thurmond, & Wai‐Ping Fung‐Leung. (2009). Phosphoinositide 3-Kinase Gamma (PI3Kγ) Inhibitors for the Treatment of Inflammation and Autoimmune Disease. Recent Patents on Inflammation & Allergy Drug Discovery. 4(1). 1–15. 23 indexed citations
10.
Ameriks, Michael K. & Jennifer D. Venable. (2009). Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ. Current Topics in Medicinal Chemistry. 9(8). 738–753. 38 indexed citations
11.
Venable, Jennifer D., et al.. (2009). Synthesis of 3-methoxy-quinoxalin-2-ones from methyl trimethoxyacetate and phenylenediamines. Tetrahedron Letters. 51(2). 337–339. 3 indexed citations
12.
Karlsson, Lars, Siquan Sun, Navin Rao, Jennifer D. Venable, & Robin L. Thurmond. (2007). TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders. Inflammation & Allergy - Drug Targets. 6(4). 223–235. 108 indexed citations
13.
Zhang, Mai, Jennifer D. Venable, & Robin L. Thurmond. (2006). The histamine H4receptor in autoimmune disease. Expert Opinion on Investigational Drugs. 15(11). 1443–1452. 41 indexed citations
14.
Venable, Jennifer D. & Robin L. Thurmond. (2006). Development and Chemistry of Histamine H4 Receptor Ligands as Potential Modulators of Inflammatory and Allergic Responses. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 5(4). 307–322. 16 indexed citations
15.
Jablonowski, Jill A., Cheryl A. Grice, Wenying Chai, et al.. (2003). The First Potent and Selective Non-Imidazole Human Histamine H4Receptor Antagonists. Journal of Medicinal Chemistry. 46(19). 3957–3960. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026